Characteristic | CLD patients (n = 42,320) | Matched controls (n = 182,147) |
---|---|---|
Females, no. (%) | 21,591 (51.0%) | 93,906 (51.6%) |
Males, no (%) | 20,729 (49.0%) | 88,241 (48.4%) |
Age at start of follow-up1 | ||
Mean (SD) | 60.9 (16.0) | 59.4 (15.6) |
Median (IQR) | 62.8 (51.8–72.8) | 61.4 (50.5–71.0) |
Range, min–max | 3.1–99.7 | 3.2–99.8 |
Categories, no. (%) | ||
< 18 years | 508 (1.2%) | 2479 (1.4%) |
18 to < 40 years | 4105 (9.7%) | 19,274 (10.6%) |
40 to < 60 years | 13,567 (32.1%) | 62,844 (34.5%) |
≥ 60 years | 24,140 (57.0%) | 97,550 (53.6%) |
Country of birth, no (%) | ||
Nordic country | 36,036 (85.2%) | 162,473 (89.2%) |
Other | 6284 (14.8%) | 19,670 (10.8%) |
Missing | 0 | 4 (0.0%) |
Level of education3, no (%) | ||
≤ 9 years | 9467 (22.4%) | 33,283 (18.3%) |
10–12 years | 20,139 (47.6%) | 83,677 (45.9%) |
> 12 years | 12,567 (29.7%) | 64,460 (35.4%) |
Missing | 147 (0.3%) | 727 (0.4%) |
Index year2 | ||
1969–1989 | 2966 (7.0%) | 11,276 (6.2%) |
1990–1999 | 11,722 (27.7%) | 47,935 (26.3%) |
2000–2009 | 15,979 (37.8%) | 69,263 (38.0%) |
2010–2017 | 11,653 (27.5%) | 53,673 (29.5%) |
Comorbidities4, ever before index date2, no. (%) | ||
Any cardiovascular disease | 5892 (13.9%) | 11,509 (6.3%) |
Diabetes | 2312 (5.5%) | 3548 (1.9%) |
Chronic obstructive pulmonary disease | 513 (1.2%) | 869 (0.5%) |
End-stage renal disease | 205 (0.5%) | 118 (0.1%) |
Alcohol use disorder | 2450 (5.8%) | 3184 (1.7%) |
Obesity/dyslipidemia | 2399 (5.7%) | 4026 (2.2%) |
Obstructive sleep apnea | 492 (1.2%) | 1490 (0.8%) |
Cancer | 5832 (13.8%) | 4327 (2.4%) |
Psychiatric disease | 5015 (11.9%) | 11,090 (6.1%) |